 SAN DIEGO, May 05, 2021 GLOBE NEWSWIRE -- AXIM Biotechnologies, Inc. OTCQB: AXIM AXIM Biotech, AXIM or the Company, an international healthcare solutions company targeting oncological and COVID-19 research, announced today that the Companys manufacturing partner Empowered Diagnostics has filed for emergency approval to use ImmunoPassTM, the Companys rapid test that semi-quantitatively measures levels of COVID-19 neutralizing antibodies, to detect COVID-19 neutralizing antibodies in whole blood at point-of-care locations throughout Canada and the EU. 